UFP Technologies

UFP Technologies is a medical device manufacturer headquartered in the United States. The company operates within the healthcare technology sector, producing devices for medical applications. Its core business involves the design and production of medical equipment, positioning it within the regulated medtech industry. The specific product lines, company size, revenue, and precise market reach are not detailed in the available information. The organization serves the medical supply chain, though its exact customer segments and geographic footprint remain unspecified. As a manufacturer, its operations are subject to industry-specific regulatory frameworks, though no particular certifications or approvals are cited. The company's specialization lies in the development of medical devices, a field requiring adherence to quality and safety protocols. Without explicit data, its competitive advantages or notable competencies cannot be confirmed. The available context does not indicate any parent company or subsidiary relationships. UFP Technologies' primary identity is that of a U.S.-based entity in the medical device manufacturing space.

In February 2026, UFP Technologies experienced a ransomware attack that compromised multiple IT systems. The incident resulted in data theft or destruction and caused short-term shipment delays for its products. The company does not expect a material financial impact from the cyber event. Insurance coverage is anticipated to offset most direct costs related to containment, mitigation, and recovery. Primary systems were projected for restoration in the near term following the attack. UFP is investigating the potential exposure of sensitive information, including personally identifiable data, as a consequence of the breach. The company is also evaluating its obligations for regulatory filings in response to the incident. This cyberattack highlights the cybersecurity risks faced by medical device manufacturers. The event underscores the importance of protecting both operational data and sensitive information within the healthcare sector. UFP's response involves coordination with insurers and assessment of regulatory requirements.